|
VBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.18619999775771E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08239999996318E-06 |
| Normal-vs-Stage2 |
7.297700E-02 |
| Normal-vs-Stage3 |
7.70480000022999E-07 |
| Normal-vs-Stage4 |
2.395000E-04 |
| Stage1-vs-Stage2 |
4.597000E-01 |
| Stage1-vs-Stage3 |
1.723840E-01 |
| Stage1-vs-Stage4 |
6.883800E-01 |
| Stage2-vs-Stage3 |
1.321570E-01 |
| Stage2-vs-Stage4 |
3.612600E-01 |
| Stage3-vs-Stage4 |
5.156600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34909999955002E-07 |
| Normal-vs-AfricanAmerican |
3.07350034312037E-10 |
| Normal-vs-Asian |
1.059690E-03 |
| Caucasian-vs-AfricanAmerican |
3.283200E-03 |
| Caucasian-vs-Asian |
3.191600E-01 |
| AfricanAmerican-vs-Asian |
7.055200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.92319999504332E-08 |
| Normal-vs-Female |
1.548600000012E-06 |
| Male-vs-Female |
6.364600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.28620000000324E-05 |
| Normal-vs-Age(41-60Yrs) |
1.1872999999829E-06 |
| Normal-vs-Age(61-80Yrs) |
1.1322999999841E-06 |
| Normal-vs-Age(81-100Yrs) |
1.197980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.103200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.629000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.391000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.393800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.045800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.995000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.641620E-02 |
| Normal-vs-Grade 2 |
3.154400E-04 |
| Normal-vs-Grade 3 |
9.88090054221402E-10 |
| Normal-vs-Grade 4 |
3.86039999999976E-05 |
| Grade 1-vs-Grade 2 |
6.571600E-01 |
| Grade 1-vs-Grade 3 |
4.516800E-01 |
| Grade 1-vs-Grade 4 |
3.494600E-01 |
| Grade 2-vs-Grade 3 |
8.304400E-03 |
| Grade 2-vs-Grade 4 |
5.720100E-02 |
| Grade 3-vs-Grade 4 |
7.615800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.359900E-03 |
| Normal-vs-ccB subtype |
5.80829999652366E-08 |
| ccA subtype-vs-ccB subtype |
5.398100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15440000000045E-05 |
| Normal-vs-N1 |
1.629780E-02 |
| N0-vs-N1 |
3.880000E-01 |
|
|
